imiquimod has been researched along with gliclazide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Fang, H; Gao, J; Guo, J; Mi, J; Mo, W; Nong, Y; Qi, Q; Yang, M | 1 |
| Chen, H; Chen, Y; Han, L; Liu, H; Lu, C; Tang, B; Yan, Y; Yu, J | 1 |
3 other study(ies) available for imiquimod and gliclazide
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
18β-Glycyrrhetinic acid induces human HaCaT keratinocytes apoptosis through ROS-mediated PI3K-Akt signaling pathway and ameliorates IMQ-induced psoriasis-like skin lesions in mice.
Topics: Animals; Apoptosis; Cell Line; Cytokines; Female; Glycyrrhetinic Acid; Humans; Imiquimod; Keratinocytes; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Psoriasis; Reactive Oxygen Species; Signal Transduction; Skin | 2020 |
The Protective Effects of 18
Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Glycyrrhetinic Acid; Imiquimod; Immunohistochemistry; Inflammation Mediators; Mice; Protective Agents; Psoriasis; Signal Transduction; STAT3 Transcription Factor; T-Lymphocyte Subsets; TOR Serine-Threonine Kinases | 2020 |